Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition
AssigneeUltraceuticals R & D Pty Ltd
InventorsGeoffrey Heber, Nicholas Patrick John Stamford
Life of this patent
Estimating the term…
Loading patent…
AssigneeUltraceuticals R & D Pty Ltd
InventorsGeoffrey Heber, Nicholas Patrick John Stamford
Estimating the term…
The present invention relates to glucommannan oligosaccharides and polysaccharides that possess one or more properties selected from skin regeneration, wound healing and skin augmentation. More particularly, the invention relates to the use of glucomannan oligosaccharides and polysaccharides for one or more of skin regeneration, wound healing and skin augmentation agents in a mammal. The invention also relates to a pharmaceutical formulation for treating skin of a subject comprising an active component comprising glucomannan in a suitable diluent, excipient or physical form such as dermal scaffold or sponge, the active component being capable of promoting an accumulation of fibroblasts in the skin and stimulating production of collagen in the skin.
A method for treating a condition of skin of a mammalian subject in need of such treatment by promoting an accumulation of fibroblasts in the skin and increasing production of collagen in skin, the method comprising delivering to the skin of the subject an active component comprising:
Dependencies are inferred from the claim text.